BIOPSY SCIENCES, LLC
CLEARWATER, FLORIDA

BIOPSY SCIENCES, LLC is a distinguished medical technology company founded by Dr. John Fisher, an interventional radiologist renowned for his expertise in breast imaging and biopsy procedures. The company was incorporated on December 28, 2000, in Clearwater, Florida, with its headquarters located at 4900 Creekside Drive, Suite C, Clearwater, FL 33760. Operating under the status of a model Florida Company, BIOPSY SCIENCES is recognized for pioneering innovative solutions in medical imaging and biopsy techniques. Under Dr. Fisher's guidance, who boasts extensive experience performing over 500 stereotactic and ultrasound-guided breast biopsies, BIOPSY SCIENCES developed the HydroMARK—a water-containing, ultrasound-visible marker aimed at enhancing patient comfort by facilitating quicker localization procedures compared to traditional mammogram guided methods. Another significant innovation is the BioSEAL biopsy tract sealant, which minimizes complications like pneumothorax and the need for chest tube placement post-CT directed lung biopsies. This product's significance was highlighted when it was acquired by Angiotech Pharmaceuticals in 2008. BIOPSY SCIENCES continues to advance medical technology with Dr. Fisher and his team at the helm, supported by managers James C Gibson, John S Fisher, and Fred Ahari. The company is dedicated to addressing clinical needs through innovation and maintains transparent communication channels for engagement with stakeholders. For inquiries or further information, they welcome contact via their phone lines (888) 819-1073, (727) 290-9825, (727) 290-9828, or email as per the instructions on their official website, biopsysciences.com.